Redirect Notice

Looks like you clickedhttps://alteritytherapeutics.com/investor-centre/news/2021/12/14/first-regulatory-authorization-to-proceed-with-ath434-phase-2-clinical-trial/

If you do not want to visit that page, you can close this browser tab.